FGF21 and metabolic disease: FGF21, belonging to of the fibroblast growth factor (FGF) family and initially discovered in the liver [50], shares approximately 75% amino acid sequence similarity between mice and humans, demonstrating potential therapeutic benefits in addressing metabolic disorders in preclinical studies.